Rxivist logo

Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities

By Venexia M Walker, George Davey Smith, Neil M Davies, Richard M Martin

Posted 02 Feb 2017
bioRxiv DOI: 10.1101/105338 (published DOI: 10.1093/ije/dyx207)

Identification of unintended drug effects, specifically drug repurposing opportunities and adverse drug events, maximizes the benefit of a drug and protects the health of patients. However, current observational research methods are subject to several biases. These include confounding by indication, reverse causality, and missing data. We propose that Mendelian randomization (MR) offers a novel approach for the prediction of unintended drug effects. In particular, we advocate the synthesis of evidence from this method and other approaches, in the spirit of triangulation, to improve causal inferences concerning drug effects. MR overcomes some of the limitations associated with the existing methods in this field. Furthermore, it can be applied either pre- or post-approval of the drug and could therefore prevent the potentially harmful exposure of patients in clinical trials and beyond. The potential of MR as a pharmacovigilance and drug repurposing tool is yet to be realized and could both help prevent adverse drug events and identify novel indications for existing drugs in the future.

Download data

  • Downloaded 996 times
  • Download rankings, all-time:
    • Site-wide: 10,842 out of 84,639
    • In pharmacology and toxicology: 64 out of 762
  • Year to date:
    • Site-wide: 78,457 out of 84,639
  • Since beginning of last month:
    • Site-wide: 70,857 out of 84,639

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)